It's inspiring when a spirit of generosity goes global. But to fight this pandemic, well-off nations must do their part. That's why we think Biden's stand on vaccine patents is a vital step.
For most people, COVID-19 vaccines promise a return to something akin to normal life. But for the hundreds of thousands of Americans who have a transplanted organ, it's a different story.
When it comes to persuading people to get a COVID-19 vaccine, health care professionals are influential. But in some rural communities, hospital staff themselves are hanging back.
Some folks are taking their first vaccine dose in a two-dose regimen, then deciding to skip the second one altogether. Or maybe to delay it longer than suggested. Is this a bad idea?
Even though COVID-19 deaths are spiking and the country is climbing out of a deep economic downturn, the president has proposed new taxes. Colombians are defying restrictions by protesting.
Researchers are trying to come up with tests that can be performed using a blood sample that will determine not only whether a COVID-19 vaccine will work but also for how long.
The Republican-led state will offer savings bonds to residents between the ages of 16 and 35 in an effort to tackle vaccine hesitancy among its younger population.
One year ago, the Navajo Nation was the site of the highest per-capita infection rate in the U.S. Now the vast majority of adults have gotten at least one COVID-19 vaccine dose.
There are some side effects that are pretty common: sore arm, headache, fatigue, fever. But people are saying they've got other unusual reactions. Is it the vaccine — or something else?
Centers for Disease Control and Prevention researchers found no obvious safety concerns in a study of 35,000 pregnant people who received the vaccines, though they say more research is needed.
In the next phase of the race to vaccinate Americans, the Biden administration knows the government is not the best messenger. So it's asking communities for help.
